Medicine guide
Revasc
·
- Prescription status not stated
- Blood, clotting and anaemia
- Active substance
- Desirudin
- Used in
- Blood, clotting and anaemia
- Made by
- Canyon Pharmaceuticals Ltd.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Prevention of deep venous thrombosis in patients undergoing elective hip or knee replacement surgery.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Canyon Pharmaceuticals Ltd. |
|---|---|
| Active substance | Desirudin |
| Used in | Blood, clotting and anaemia |
| Classification | B01AE01 · Blood, clotting and anaemia |
| Authorised on | 1997-07-09 |
| Last updated by the regulator | 2014-07-29 |
| EMA product number | EMEA/H/C/000104 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).